Clinical Trials Browser

Phase 2/3 × Osteosarcoma × apatinib × Clear all

NCT02711007 2018-04-23

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

Phase 2/3 Completed

Neoplasm Metastasis, Osteosarcoma